391 related articles for article (PubMed ID: 12697826)
41. Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2.
Cannavo E; Gerrits B; Marra G; Schlapbach R; Jiricny J
J Biol Chem; 2007 Feb; 282(5):2976-86. PubMed ID: 17148452
[TBL] [Abstract][Full Text] [Related]
42. Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX.
Mac Partlin M; Homer E; Robinson H; McCormick CJ; Crouch DH; Durant ST; Matheson EC; Hall AG; Gillespie DA; Brown R
Oncogene; 2003 Feb; 22(6):819-25. PubMed ID: 12584560
[TBL] [Abstract][Full Text] [Related]
43. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
[No Abstract] [Full Text] [Related]
44. A review of mismatch repair gene transcripts: issues for interpretation of mRNA splicing assays.
Thompson BA; Martins A; Spurdle AB
Clin Genet; 2015 Feb; 87(2):100-8. PubMed ID: 24989436
[TBL] [Abstract][Full Text] [Related]
45. Loss of DNA-mismatch repair gene expression in oral melanomas.
Korabiowska M; Brinck U; Ruschenburg I; Honig JF; Stachura J; Droese M
Oncol Rep; 1999; 6(4):921-3. PubMed ID: 10373682
[TBL] [Abstract][Full Text] [Related]
46. Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.
Felsberg J; Thon N; Eigenbrod S; Hentschel B; Sabel MC; Westphal M; Schackert G; Kreth FW; Pietsch T; Löffler M; Weller M; Reifenberger G; Tonn JC;
Int J Cancer; 2011 Aug; 129(3):659-70. PubMed ID: 21425258
[TBL] [Abstract][Full Text] [Related]
47. ATP-dependent interaction of human mismatch repair proteins and dual role of PCNA in mismatch repair.
Gu L; Hong Y; McCulloch S; Watanabe H; Li GM
Nucleic Acids Res; 1998 Mar; 26(5):1173-8. PubMed ID: 9469823
[TBL] [Abstract][Full Text] [Related]
48. Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents.
Francia G; Green SK; Bocci G; Man S; Emmenegger U; Ebos JM; Weinerman A; Shaked Y; Kerbel RS
Mol Cancer Ther; 2005 Oct; 4(10):1484-94. PubMed ID: 16227397
[TBL] [Abstract][Full Text] [Related]
49. In vitro and in vivo modulations of benzo[c]phenanthrene-DNA adducts by DNA mismatch repair system.
Wu J; Zhu BB; Yu J; Zhu H; Qiu L; Kindy MS; Gu L; Seidel A; Li GM
Nucleic Acids Res; 2003 Nov; 31(22):6428-34. PubMed ID: 14602900
[TBL] [Abstract][Full Text] [Related]
50. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
[TBL] [Abstract][Full Text] [Related]
51. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair.
Prolla TA; Baker SM; Harris AC; Tsao JL; Yao X; Bronner CE; Zheng B; Gordon M; Reneker J; Arnheim N; Shibata D; Bradley A; Liskay RM
Nat Genet; 1998 Mar; 18(3):276-9. PubMed ID: 9500552
[TBL] [Abstract][Full Text] [Related]
52. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
53. Expression of five selected human mismatch repair genes simultaneously detected in normal and cancer cell lines by a nonradioactive multiplex reverse transcription-polymerase chain reaction.
Wei Q; Guan Y; Cheng L; Radinsky R; Bar-Eli M; Tsan R; Li L; Legerski RJ
Pathobiology; 1997; 65(6):293-300. PubMed ID: 9491849
[TBL] [Abstract][Full Text] [Related]
54. Expression of DNA mismatch repair genes in naevi.
Korabiowska M; Brinck U; Ruschenburg I; Dengler H; Droese M; Berger H
In Vivo; 1999; 13(3):251-4. PubMed ID: 10459502
[TBL] [Abstract][Full Text] [Related]
55. Mutational analysis of transforming growth factor beta receptor type II and DNA mismatch repair genes in sporadic endometrial carcinomas with microsatellite instability.
Ohwada M; Suzuki M; Saga Y; Suzuki T; Ikeda M; Yamada M; Sato I
Oncol Rep; 2000; 7(4):789-92. PubMed ID: 10854545
[TBL] [Abstract][Full Text] [Related]
56. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer.
Raedle J; Trojan J; Brieger A; Weber N; Schäfer D; Plotz G; Staib-Sebler E; Kriener S; Lorenz M; Zeuzem S
Ann Intern Med; 2001 Oct; 135(8 Pt 1):566-76. PubMed ID: 11601928
[TBL] [Abstract][Full Text] [Related]
57. Mismatch repair pathway: molecules, functions, and role in colorectal carcinogenesis.
Sameer AS; Nissar S; Fatima K
Eur J Cancer Prev; 2014 Jul; 23(4):246-57. PubMed ID: 24614649
[TBL] [Abstract][Full Text] [Related]
58. Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs.
Hinrichsen I; Kemp M; Peveling-Oberhag J; Passmann S; Plotz G; Zeuzem S; Brieger A
PLoS One; 2014; 9(1):e84453. PubMed ID: 24400091
[TBL] [Abstract][Full Text] [Related]
59. Reduced expression of human mismatch repair genes in adult T-cell leukemia.
Morimoto H; Tsukada J; Kominato Y; Tanaka Y
Am J Hematol; 2005 Feb; 78(2):100-7. PubMed ID: 15682421
[TBL] [Abstract][Full Text] [Related]
60. ATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage.
Luo Y; Lin FT; Lin WC
Mol Cell Biol; 2004 Jul; 24(14):6430-44. PubMed ID: 15226443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
